In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
November 15th, 2005 | 29 | Yes |
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 6.88 | 11.69 | -8.39 | 2 | 3 | 0 | 49 | 391.555 | 6 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
therap | antineoplastic | MicroSource Pharmakon |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
RET1-1-E | Cellular Retinol-binding Protein (cluster #1 Of 1), Eukaryotic | Eukaryotes | 170 | 0.33 | Binding ≤ 10μM |
RET2-1-E | Cellular Retinol-binding Protein II (cluster #1 Of 1), Eukaryotic | Eukaryotes | 170 | 0.33 | Binding ≤ 10μM |
RET3-1-E | Interstitial Retinol-binding Protein (cluster #1 Of 1), Eukaryotic | Eukaryotes | 170 | 0.33 | Binding ≤ 10μM |
RET4-1-E | Plasma Retinol-binding Protein (cluster #1 Of 1), Eukaryotic | Eukaryotes | 170 | 0.33 | Binding ≤ 10μM |
RET5-1-E | Cellular Retinol-binding Protein III (cluster #1 Of 1), Eukaryotic | Eukaryotes | 170 | 0.33 | Binding ≤ 10μM |
RET7-1-E | Cellular Retinol-binding Protein IV (cluster #1 Of 1), Eukaryotic | Eukaryotes | 170 | 0.33 | Binding ≤ 10μM |
RET4-1-E | Plasma Retinol-binding Protein (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2372 | 0.27 | Functional ≤ 10μM |
Z50425-4-O | Plasmodium Falciparum (cluster #4 Of 22), Other | Other | 7943 | 0.25 | Functional ≤ 10μM |
Z80224-2-O | MCF7 (Breast Carcinoma Cells) (cluster #2 Of 14), Other | Other | 150 | 0.33 | Functional ≤ 10μM |
Z80390-8-O | PC-3 (Prostate Carcinoma Cells) (cluster #8 Of 10), Other | Other | 3600 | 0.26 | Functional ≤ 10μM |
Z81170-1-O | LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other | Other | 7500 | 0.25 | Functional ≤ 10μM |
Z81252-3-O | MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other | Other | 7700 | 0.25 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
RET1_HUMAN | P09455 | Cellular Retinol-binding Protein, Human | 170 | 0.33 | Binding ≤ 1μM |
RET2_HUMAN | P50120 | Cellular Retinol-binding Protein II, Human | 170 | 0.33 | Binding ≤ 1μM |
RET5_HUMAN | P82980 | Cellular Retinol-binding Protein III, Human | 170 | 0.33 | Binding ≤ 1μM |
RET7_HUMAN | Q96R05 | Cellular Retinol-binding Protein IV, Human | 170 | 0.33 | Binding ≤ 1μM |
RET3_HUMAN | P10745 | Interstitial Retinol-binding Protein, Human | 170 | 0.33 | Binding ≤ 1μM |
RET4_HUMAN | P02753 | Plasma Retinol-binding Protein, Human | 170 | 0.33 | Binding ≤ 1μM |
RET1_HUMAN | P09455 | Cellular Retinol-binding Protein, Human | 170 | 0.33 | Binding ≤ 10μM |
RET2_HUMAN | P50120 | Cellular Retinol-binding Protein II, Human | 170 | 0.33 | Binding ≤ 10μM |
RET5_HUMAN | P82980 | Cellular Retinol-binding Protein III, Human | 170 | 0.33 | Binding ≤ 10μM |
RET7_HUMAN | Q96R05 | Cellular Retinol-binding Protein IV, Human | 170 | 0.33 | Binding ≤ 10μM |
RET3_HUMAN | P10745 | Interstitial Retinol-binding Protein, Human | 170 | 0.33 | Binding ≤ 10μM |
RET4_HUMAN | P02753 | Plasma Retinol-binding Protein, Human | 170 | 0.33 | Binding ≤ 10μM |
Z81170 | Z81170 | LNCaP (Prostate Carcinoma) | 7500 | 0.25 | Functional ≤ 10μM |
Z80224 | Z80224 | MCF7 (Breast Carcinoma Cells) | 150 | 0.33 | Functional ≤ 10μM |
Z81252 | Z81252 | MDA-MB-231 (Breast Adenocarcinoma Cells) | 7700 | 0.25 | Functional ≤ 10μM |
Z80390 | Z80390 | PC-3 (Prostate Carcinoma Cells) | 3600 | 0.26 | Functional ≤ 10μM |
RET4_HUMAN | P02753 | Plasma Retinol-binding Protein, Human | 2372 | 0.27 | Functional ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 3981.07171 | 0.26 | Functional ≤ 10μM |
Description | Species |
---|---|
Retinoid cycle disease events | |
Retinoid metabolism and transport | |
The canonical retinoid cycle in rods (twilight vision) | |
The retinoid cycle in cones (daylight vision) |